These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23283577)

  • 1. Central statistical monitoring: detecting fraud in clinical trials.
    Pogue JM; Devereaux PJ; Thorlund K; Yusuf S
    Clin Trials; 2013 Apr; 10(2):225-35. PubMed ID: 23283577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A computationally simple central monitoring procedure, effectively applied to empirical trial data with known fraud.
    van den Bor RM; Vaessen PWJ; Oosterman BJ; Zuithoff NPA; Grobbee DE; Roes KCB
    J Clin Epidemiol; 2017 Jul; 87():59-69. PubMed ID: 28412468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A statistical approach to central monitoring of data quality in clinical trials.
    Venet D; Doffagne E; Burzykowski T; Beckers F; Tellier Y; Genevois-Marlin E; Becker U; Bee V; Wilson V; Legrand C; Buyse M
    Clin Trials; 2012 Dec; 9(6):705-13. PubMed ID: 22684241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of methods for central statistical monitoring in clinical trials.
    Kirkwood AA; Cox T; Hackshaw A
    Clin Trials; 2013 Oct; 10(5):783-806. PubMed ID: 24130202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting data fabrication in clinical trials from cluster analysis perspective.
    Wu X; Carlsson M
    Pharm Stat; 2011; 10(3):257-64. PubMed ID: 20936626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative infection treatment score for the spine (PITSS): construction and validation of a predictive model to define need for single versus multiple irrigation and debridement for spinal surgical site infection.
    Dipaola CP; Saravanja DD; Boriani L; Zhang H; Boyd MC; Kwon BK; Paquette SJ; Dvorak MF; Fisher CG; Street JT
    Spine J; 2012 Mar; 12(3):218-30. PubMed ID: 22386957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the decision in a validation process of a surrogate endpoint change with level of significance of treatment effect? A proposal on validation of surrogate endpoints.
    Sertdemir Y; Burgut R
    Contemp Clin Trials; 2009 Jan; 30(1):8-12. PubMed ID: 18809512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical considerations on design and analysis of bridging and multiregional clinical trials.
    Tsong Y
    J Biopharm Stat; 2012 Sep; 22(5):1078-80. PubMed ID: 22946952
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictive event modelling in multicenter clinical trials with waiting time to response.
    Anisimov VV
    Pharm Stat; 2011; 10(6):517-22. PubMed ID: 22140055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Appraisal of the Carlisle-Stouffer-Fisher Method for Assessing Study Data Integrity and Fraud.
    Mascha EJ; Vetter TR; Pittet JF
    Anesth Analg; 2017 Oct; 125(4):1381-1385. PubMed ID: 28786843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk analysis and risk adapted on-site monitoring in noncommercial clinical trials.
    Brosteanu O; Houben P; Ihrig K; Ohmann C; Paulus U; Pfistner B; Schwarz G; Strenge-Hesse A; Zettelmeyer U
    Clin Trials; 2009 Dec; 6(6):585-96. PubMed ID: 19897532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of atypical data in multicenter clinical trials using unsupervised statistical monitoring.
    Trotta L; Kabeya Y; Buyse M; Doffagne E; Venet D; Desmet L; Burzykowski T; Tsuburaya A; Yoshida K; Miyashita Y; Morita S; Sakamoto J; Praveen P; Oba K
    Clin Trials; 2019 Oct; 16(5):512-522. PubMed ID: 31331195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linear mixed-effects models for central statistical monitoring of multicenter clinical trials.
    Desmet L; Venet D; Doffagne E; Timmermans C; Burzykowski T; Legrand C; Buyse M
    Stat Med; 2014 Dec; 33(30):5265-79. PubMed ID: 25213096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative consistency of treatment effects in multiregional clinical trials.
    Tanaka Y; Li G; Wang Y; Chen J
    J Biopharm Stat; 2012 Sep; 22(5):988-1000. PubMed ID: 22946945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementing a low-cost web-based clinical trial management system for community studies: a case study.
    Geyer J; Myers K; Vander Stoep A; McCarty C; Palmer N; DeSalvo A
    Clin Trials; 2011 Oct; 8(5):634-44. PubMed ID: 21813582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian approaches in medical device clinical trials: a discussion with examples in the regulatory setting.
    Bonangelino P; Irony T; Liang S; Li X; Mukhi V; Ruan S; Xu Y; Yang X; Wang C
    J Biopharm Stat; 2011 Sep; 21(5):938-53. PubMed ID: 21830924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conduct of multicenter trials to test agents for treatment of periodontitis.
    Goodson JM
    J Periodontol; 1992 Dec; 63(12 Suppl):1058-63. PubMed ID: 1479526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graphical assessment of consistency in treatment effect among countries in multi-regional clinical trials.
    Chen J; Zheng H; Quan H; Li G; Gallo P; Ouyang SP; Binkowitz B; Ting N; Tanaka Y; Luo X; Ibia E;
    Clin Trials; 2013; 10(6):842-51. PubMed ID: 24013404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating heterogeneity in indoor and outdoor air pollution using land-use regression and constrained factor analysis.
    Levy JI; Clougherty JE; Baxter LK; Houseman EA; Paciorek CJ;
    Res Rep Health Eff Inst; 2010 Dec; (152):5-80; discussion 81-91. PubMed ID: 21409949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.